These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21307880)

  • 21. Visual improvement in central retinal vein occlusion (CRVO) following intravitreal injections of bevacizumab (Avastin(®) ).
    Algvere PV; Von Wendt G; Gudmundsson J; Seregard S; Kvanta A
    Acta Ophthalmol; 2010 Dec; 88(8):836-41. PubMed ID: 19900206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion persisting despite multiple intravitreal bevacizumab injections.
    Alshareef RA; Garg SJ; Hsu J; Vander J; Park C; Spirn MJ
    J Ocul Pharmacol Ther; 2014 Aug; 30(6):512-6. PubMed ID: 24828198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion.
    Ach T; Hoeh AE; Schaal KB; Scheuerle AF; Dithmar S
    Graefes Arch Clin Exp Ophthalmol; 2010 Feb; 248(2):155-9. PubMed ID: 19763601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion.
    Wu WC; Cheng KC; Wu HJ
    Eye (Lond); 2009 Dec; 23(12):2215-22. PubMed ID: 19218991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
    Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA
    Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of peripheral laser photocoagulation with intravitreal bevacizumab in naïve eyes with macular edema secondary to CRVO: prospective randomized study.
    Chhablani J; Narayanan R; Mathai A; Tyagi M
    Eye (Lond); 2016 Jul; 30(7):1025-7. PubMed ID: 27034198
    [No Abstract]   [Full Text] [Related]  

  • 28. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal bevacizumab treatment of macular edema in central retinal vein occlusion: one-year results.
    Beutel J; Ziemssen F; Lüke M; Partsch M; Bartz-Schmidt KU; ; Gelisken F
    Int Ophthalmol; 2010 Feb; 30(1):15-22. PubMed ID: 19099203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comment on: 'Combination of peripheral laser photocoagulation with intravitreal bevacizumab in naive eyes with macular edema secondary to CRVO: prospective randomized study'.
    Călugăru D; Călugăru M
    Eye (Lond); 2016 Nov; 30(11):1520-1521. PubMed ID: 27285320
    [No Abstract]   [Full Text] [Related]  

  • 31. The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions.
    Ivanovska Adjievska B; Boskurt S; Orovcanec N; Dimovska-Jordanova V
    Clin Ophthalmol; 2017; 11():1183-1190. PubMed ID: 28790803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
    Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
    Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion.
    Russo V; Barone A; Conte E; Prascina F; Stella A; Noci ND
    Retina; 2009 Apr; 29(4):511-5. PubMed ID: 19174717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapies for macular edema associated with central retinal vein occlusion: a report by the American Academy of Ophthalmology.
    Yeh S; Kim SJ; Ho AC; Schoenberger SD; Bakri SJ; Ehlers JP; Thorne JE
    Ophthalmology; 2015 Apr; 122(4):769-78. PubMed ID: 25576994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early intravitreal bevacizumab for non-ischaemic central retinal vein occlusion.
    Rensch F; Jonas JB; Spandau UH
    Acta Ophthalmol; 2009 Feb; 87(1):77-81. PubMed ID: 18937800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trial.
    Pielen A; Mirshahi A; Feltgen N; Lorenz K; Korb C; Junker B; Schaefer C; Zwiener I; Hattenbach LO;
    Acta Ophthalmol; 2015 Feb; 93(1):e29-37. PubMed ID: 25042729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial.
    Priglinger SG; Wolf AH; Kreutzer TC; Kook D; Hofer A; Strauss RW; Alge CS; Kunze C; Haritoglou C; Kampik A
    Retina; 2007 Oct; 27(8):1004-12. PubMed ID: 18040236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months.
    Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ
    Retina; 2010; 30(7):1002-11. PubMed ID: 20616679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial.
    Prager F; Michels S; Kriechbaum K; Georgopoulos M; Funk M; Geitzenauer W; Polak K; Schmidt-Erfurth U
    Br J Ophthalmol; 2009 Apr; 93(4):452-6. PubMed ID: 19074916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
    Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
    Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.